[药理疗法用于提高青春期矮身儿童的身高]
Jian-Fang Zhu1, Chun-Lin Wang1
1Department of Pediatrics,First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China (Wang C-L, Email: hzwangcl@zju.edu. cn).
概括
青春期的矮身影响青少年的健康. 本综述总结了当前的药理疗法,如生长激素和芳香酶抑制剂,以优化最终的成年人身高,帮助临床实践.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 青少年医学 青少年医学
- 药理学研究 药理学研究
背景情况:
- 青春期的矮身对青少年来说带来了重大的身体和心理健康挑战.
- 由于性激素加速骨成熟,限制了生长潜力,使治疗复杂化.
- 目前还没有针对青春期矮身的标准化治疗方案.
研究的目的:
- 提供药理疗法的综合摘要,以改善青春期儿童的身高.
- 突出最近个性化治疗方法的进展.
- 为管理这种疾病的医疗保健专业人员提供见解.
主要方法:
- 审查当前关于药理干预药理干预青春期矮身的文献.
- 分析常用的治疗方法,包括复合人体生长激素,淋巴激素释放激素类型和芳香酶抑制剂.
- 探索个性化的治疗策略.
主要成果:
- 药物治疗对于在关键的青春期生长阶段改善身高至关重要.
- 重组人体生长激素,GnRH类似物和芳酶抑制剂是关键的治疗选择.
- 个性化治疗计划正在成为优化最终成年人身高的重点.
结论:
- 青春期为改善矮身儿童成年人身高的干预提供了最后一个窗口.
- 有一系列的药理选择存在,个性化的方法越来越重要.
- 需要进一步的研究和标准化的协议来优化治疗结果.
相关概念视频
Nature and Nurture
20.5K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.5K
Signs of Puberty
347
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
347
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
157
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
157
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166


